4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000114
CHIEF OPERATING OFFICER sold 8,000 shares at an average $92.49 ($739,885)
- CHIEF OPERATING OFFICER acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wassil Jim CHIEF OPERATING OFFICER | 2024-12-02 | Option exercise 10b5-1 | +8,000 | $2.42 | $19,360 | 213,695 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-12-02 | Sale 10b5-1 | −5,772 | $92.07 | $531,416 | 207,923 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-12-02 | Sale 10b5-1 | −1,101 | $93.06 | $102,460 | 206,822 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-12-02 | Sale 10b5-1 | −1,127 | $94.06 | $106,008 | 205,695 | D |
| Derivatives | |||||||
| Wassil Jim CHIEF OPERATING OFFICER | 2024-12-02 | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 18,638 | D | ||
| Open-market sales · 8,000 sh · avg $92.49 · $739,885 | |||||||
Loading xslF345X05/wk-form4_1733271231.xml…